| Research Base |
Protocol Number |
Title (with link to PDQ Listing) |
Cancer Control |
Follow Up Credit |
| CALGB |
CALGB
70501 |
Collection of Patient Reported Symptoms and Performance Status via the Internet |
1.0 |
N/A |
| CALGB |
70305 |
A Randomized Study to Prevent Lymphedema in Women Treated for Breast Cancer |
1.0 |
N/A |
| COG |
ACCL05C1 |
Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy |
1.0 |
N/A |
| COG |
AALL03N1 |
Understanding the Ethnic and Racial Differences in Survival in Children with Acute Lymphoblastic Leukemia |
0.5 |
N/A |
| COG |
ACCL04C2 |
Randomized Study of Electroacupuncture Treatment for Delayed Chemotherapy-
Induced Nausea and Vomiting in Patients with Pediatric Solid Tumors |
1.0 |
N/A |
| COG |
ACCL0131 |
Study of Clinical and Neurological Evidence of Methotrexate Leukoencephalo-
pathy in Children Previously Treated on Protocols POG-9605 and POG-9201 |
0.7 |
N/A |
| COG |
ACCL0331 |
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel S for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplatation |
1.0 |
N/A |
| COG |
ALTE04N1 |
Health-Related Outcomes for Hodgkins Disease Survivors |
0.5 |
N/A |
| COG |
ALTE02C2 |
Neurobehavioral Outcomes in Childhood Acute Lymphoblastic Leukemia. A Limited Non-Therapeutic Study |
0.5 |
N/A |
| COG |
ANUR0532 |
Prevention of Mucositis in Children with AES-14 (IND #36978), a Glutamine Based Oral Care Regimen, for Patients Diagnosed with Solid Tumors: A Randomized Placebo-controlled Clinical Study |
1.0 |
N/A |
| COG |
ANUR0631 |
Music Video and Adolescent/Young Adult Resilience During Transplant |
1.0 |
N/A |
| ECOG |
E2Z02 |
A Survey of Disease and Treatment-Related Symptoms in Patients with Invasive Cancer: Prevalence, Severity and Treatment |
1.0 |
N/A |
| ECOG |
E2Z04 |
Quality of Life in Younger Breast Cancer Survivors |
0.5 |
N/A |
| ECOG |
E4Z02 |
Phase III Randomized Controlled Trial to Determine Efficacy of L-Carnitine Supplementation for Fatigue in Patients with Cancer |
1.0 |
N/A |
| ECOG |
E5597 |
Phase III Chemoprevention Trial of Selenium Supplementation in Persons with Resected Stage I Non-Small Cell Lung Cancer |
1.0 |
0.3 |
| ECOG |
E5Z02 |
Phase II Protocol: Gemcitabine for Metastatic Cancer with Unknown Primary Site - Analysis of Symptom Benefit |
1.0 |
N/A |
| FCRB |
04-002-P |
Efficacy and Feasibility of a Psychosocial Intervention within the CCOP Context: Evaluation of the Facing Forward Guide to Facilitate Life after Active Cancer Treatment |
1.0 |
N/A |
| FCRB |
04-003-P |
Comparing The Lozenge To The Patch For Smoking Cesssation |
1.0 |
N/A |
| FCRB |
04-004-P |
Colorectal Cancer Screening Intervention For Family Members of Colorectal Cancer Patients |
0.5 |
N/A |
| GOG |
GOG-0199 |
Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer |
0.9 |
N/A |
| GOG |
0207 |
A Randomized Double-Blind Phase II Trial of Celecoxib, A Cox-2 Inhibitor, in the Treatment of Patients with Cervical Intraepithelial Neoplasia 3 (CIN 3) |
1.0 |
N/A |
| GOG |
0215 |
A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Risk-Reducing Surgery That Results in Removal of Both Ovaries |
1.0 |
N/A |
| GOG |
0190 |
Randomized Study of Fenretinide as Chemoprevention in Patients at Increased Risk for Ovarian Cancer |
1.0 |
N/A |
| GOG |
0192 |
Phase III Randomized Study of Amifostine Versus No Treatment For Platinum-Induced Peripheral Neuropathy in Patients With Malignancies |
1.0 |
N/A |
| HLMCC |
05-01 |
Stress Management Therapy for Patients undergoing Chemotherapy |
1.0 |
N/A |
| HLMCC |
0205 |
Study of Cyproheptadine and Megestrol in Preventing Further Weight Loss In Children with Cancer or Cancer Treatment-Related Cachexia |
1.0 |
N/A |
| HLMCC |
0203 |
Preservation of Ovarian Function in Young Women Treated with (Neo) Adjuvant Chemotherapy for Breast Cancer: A Randomized Trial Using the GnRH Agonist (Triptorelin) During Chemotherapy |
1.0 |
N/A |
| HLMCC |
02 01 |
Phase II Randomized Study of Dextroamphetamine-
Amphetamine Versus Methylphenidate in Pediatric Cancer Patients With Treatment-Related Neurocognitive Sequelae and Depression |
1.0 |
N/A |
| HLMCC |
01-05 |
Randomized Pilot Study of Isoflavones Versus Lycopene Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer |
1.0 |
N/A |
| HLMCC |
0402 |
Glutamic Acid to Decrease Vincristine Toxicity in Children with Cancer |
1.0 |
N/A |
| HLMCC |
05-02 |
Thyroid function & breast cancer: A pilot study to estimate the prevalence of thyroid dysfunction in women diagnosed with breast cancer and the magnitude of change in thyroid function post-chemotherapy |
1.0 |
N/A |
| MDA |
ID93-004 |
Prospective, Randomized Trial Comparing Heparin and Minocycline-EDTA Flush for the Prevention of Catheter-Related Infections and Occlusions |
1.0 |
N/A |
| MDA |
03-26 |
A Multicenter Phase III Placebo-Controlled Trial of Celecoxib for Prevention of Capecitabine-Induced Palmar/Plantar (Hand/Foot) Syndrome in Patients with Metastatic Breast and Colorectal Cancer |
1.0 |
N/A |
| MDA |
MDA-03-27 |
Prevention of Cisplatin or Oxaliplatin Induced Peripheral Neuropathy with Alpha-Lipoic Acid: A Placebo-Controlled Phase III Trial |
1.0 |
N/A |
| MDA |
02-23 |
Phase II Trial of Subcutaneous Amifostine for Reversal of Persistent Paclitaxel-Induced Peripheral Neuropathy |
1.0 |
N/A |
| MDA |
01-06 |
Chemotherapy and Mindfulness Relaxation: A Randomized Trial |
1.0 |
N/A |
| NCCTG |
N04CA |
Pilocarpine for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study |
1.0 |
N/A |
| NCCTG |
N05C7 |
Long Acting Methylphenidate (Concerta®) for Cancer-Related Fatigue: A Phase III, Double-Blind, Placebo-Controlled Study |
1.0 |
N/A |
| NCCTG |
N00C1 |
Phase III Placebo-Controlled, Randomized, Double-Blind Comparison of Etanercept (Enbrel [R]) Versus Placebo for the Treatment of Cancer-Associated Weight Loss and Anorexia |
1.0 |
0.0 |
| NCCTG |
N02C4 |
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss |
1.0 |
N/A |
| NCCTG |
N01C8 |
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double Blind Study |
1.0 |
N/A |
| NCCTG |
N01C5 |
Phase III Randomized Study of Valeriana Officinalis (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy |
1.0 |
N/A |
| NCCTG |
N01C3 |
Phase III Randomized Study of Lamotrigine for Chemotherapy-
Induced Peripheral Neuropathy in Patients With Cancer |
1.0 |
N/A |
| NCCTG |
N01CB |
Phase III Randomized Study of Lidocaine Patch in Cancer Patients With Postsurgical Neuropathic Pain |
1.0 |
N/A |
| NCCTG |
N00C9 |
Randomized Study of EGb761 for the Prevention of Chemotherapy-
Related Cognitive Dysfunction in Women With Breast Cancer |
1.0 |
N/A |
| NCCTG |
N00CB |
Phase III Randomized Study of Gabapentin for the Management of Hot Flashes in Patients With Prostate Cancer |
1.0 |
N/A |
| NCCTG |
N00C3 |
Phase III Randomized Study of Gabapentin in Cancer Patients With Chemotherapy-
Induced Peripheral Neuropathy |
1.0 |
N/A |
| NCCTG |
N03CA |
The Use of American Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double Blind, Dose-Finding, Placebo-Controlled Study |
1.0 |
N/A |
| NCCTG |
N04C2 |
An Exploratory, Randomized, Placebo-Controlled Trial of Depot Octreotide (Sandostatin LAR® Depot) for Intractable Ascites in Cancer Patients |
1.0 |
N/A |
| NCCTG |
N04C7 |
Placebo-Controlled Phase III Study of Intravenous Calcium/Magnesium as Prophylaxis of Oxaliplatin-Induced Sensory Neurotoxicity |
1.0 |
N/A |
| NCCTG |
N05C3 |
The Use of Vitamin E for Prevention of Chemotherapy-
Induced Peripheral Neuropathy: A Double-Blind Placebo-Controlled Study |
1.0 |
N/A |
| NCCTG |
N05C4 |
A Phase III, Randomized, Double-blind, Placebo-controlled Trial of Prophylactic Topical Sunscreen to Prevent Erlotinib- or Cetuximab-Induced Skin Rash [or Other Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Skin Rash] |
1.0 |
|
| NCCTG |
N05C5 |
A Phase III Randomized, Placebo-Controlled, Double-Blind Trial to Determine the Effectiveness of a Urea Based Topical Keratolytic Agent and Vitamin B-6 for Prevention of Capecitabine-Induced Hand and Foot Syndrome |
1.0 |
N/A |
| NCCTG |
N0569 |
Phase III Randomized, Double-blind, Placebo-controlled Evaluation of Citalopram for the Treatment of Hot Flashes |
1.0 |
N/A |
| NSABP |
LTS-01 |
Patient Reported Outcomes in Long Term Survivors with Colon and Rectal Cancer |
0.5 |
N/A |
| NSABP |
P-3 |
Celecoxib Polyp Prevention Trial In Participants with Resected Stage 1 Colon Cancer |
1.0 |
0.3 |
| NSABP |
NSABP P-2** |
Phase III Randomized Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer |
1.0 |
0.3 |
| RTOG |
0435 |
A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin For the Reduction of Oral Mucositis in Patients with Locally Advanced Head and Neck Cancer receiving Radiation Therapy with Concurrent Chemotherapy (Followed by Surgery for Selected Patients) |
1.0 |
|
| RTOG |
0517 |
Randomized Phase III Trial to Evaluate Radiopharmaceuti-
cals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast, and Prostate Cancer |
1.0 |
N/A |
| RTOG |
0518 |
A Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Zometa® for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy and Long Term LHRH Agonists for Locally Advanced Prostate Cancer |
1.0 |
N/A |
| RTOG |
0433 |
A Phase III International Radomized Trial of Single Versus Multiple Fractions For Re-Irradiation of Painful Bone Metastases |
1.0 |
N/A |
| RTOG |
L-0123 |
Phase II Randomized Study of Captopril Versus Observation in Patients With Stage II-IIIB Non-Small Cell Lung Cancer, Stage I Central Non-Small Cell Lung Cancer, or Limited Stage Small Cell Lung Cancer Previously Treated With Radiotherapy With or Without Chemotherapy |
1.0 |
N/A |
| SWOG |
S0300 |
Randomized Placebo-Controlled Biomarker Modulation Trial Using Celecoxib in Women at High Risk for Breast Cancer |
1.0 |
N/A |
| SWOG |
S0308 |
A Phase III Randomized, Multicenter Non-Inferiority Trial Evaluating the Efficacy of Oral Ibandronate versus Intravenous Zoledronate in the Reduction of Skeletal-Related Events in Patients with Metastatic Breast Cancer |
1.0 |
N/A |
| SWOG |
S0230 |
Goserelin in Preventing Ovarian Failure in Women Receiving Adjuvant Chemotherapy for Breast Cancer |
1.0 |
N/A |
| SWOG |
S0229 |
A Randomized Trial Assessing the Effects of Exercise on Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Undergoing Curative Intent Combined Modality Therapy (Ancillary to S0023 |
1.0 |
N/A |
| SWOG |
S0212 |
Phase IIb Randomized Study of Celecoxib in Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix |
1.0 |
N/A |
| SWOG |
S0000** |
Phase III Randomized Study of Selenium and Vitamin E for the Prevention of Prostate Cancer (SELECT Trial) |
1.0 |
0.3 |
| SWOG |
S9917 |
Phase III Randomized Study of Selenium as Chemoprevention of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia |
1.0 |
0.3 |
| UMCC |
02-02 |
Prostate Cancer: Impact of Fat and Flaxseed - Modified Diets. |
1.0 |
N/A |
| UMCC |
02-01 |
Phase II Trial of Encapsulized Ginger as a Treatment for Chemotherapy-
Induced Nausea and Vomiting |
1.0 |
N/A |
| UMCC |
0003 |
Proteomics Biomarker Development Laboratory |
0.2 |
0.1 (if applicable) |
| URCC |
U1701 |
Randomized Study of Buspirone in Patients With Dyspnea Associated With Malignant Disease |
1.0 |
N/A |
| URCC |
U2901 |
Phase III Randomized Study of Modafinil for Fatigue in Cancer Patients Receiving Chemotherapy |
1.0 |
N/A |
| URCC |
01-14 |
Phase II/III Randomized Study of Ginger for Chemotherapy-
Related Nausea in Patients With Cancer |
1.0 |
N/A |
| URCC |
04-01 |
Yoga for Persistent Sleep Disturbance in Cancer Survivors |
1.0 |
N/A |
| URCC |
04-02 |
Prevention of Delayed Nausea: A Phase III Double-Blind Placebo-Controlled Clinical Trial |
1.0 |
N/A |
| URCC |
5012 |
Phase III Randomized Study of Gemcitabine With or Without Dalteparin in Patients With Unresectable or Metastatic Pancreatic Cancer |
1.0 |
N/A |
| URCC |
C95-0001 |
Oral Antibotic Prophylaxis of Early Infection in Multiple Myeloma |
1.0 |
N/A |
| WFU |
91105 |
Phase III Double Blind Placebo Controlled Study of Donepezil in the Irradiated Brain |
1.0 |
N/A |
| WFU |
01-12 |
Phase II Randomized Study of Fruit and Vegetable Extracts in Patients With Stage I-III Head and Neck Cancer |
1.0 |
N/A |
| WFU |
01-03 |
Phase III Randomized Study of the Effect of Oxandrolone Versus Megestrol on Lean Body Mass, Weight, Body Fat, and Quality of Life in Patients With Solid Tumors and Weight Loss Who Are Receiving Chemotherapy |
1.0 |
N/A |
| WFU |
98301 |
A Phase II Study of St. John's Wort for the Treatment of Hot Flashes in Women with a History of Breast Cancer |
1.0 |
N/A |
| WFU |
97202 |
A Randomized Double Blind Placebo Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Cancer Treatment Related Fatigue in Breast Cancer Patients |
1.0 |
N/A |
| WFU |
97405 |
Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer |
1.0 |
N/A |
